Literature DB >> 8743084

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

T Harrer1, E Harrer, S A Kalams, T Elbeik, S I Staprans, M B Feinberg, Y Cao, D D Ho, T Yilma, A M Caliendo, R P Johnson, S P Buchbinder, B D Walker.   

Abstract

Some individuals in well-defined cohorts have now been infected with HIV-1 for well over a decade and yet remain clinically asymptomatic with normal CD4 counts. To determine immunologic and virologic parameters in these individuals, we examined 10 persons from the San Francisco City Clinic with firmly documented infection of 11-15 years duration who had maintained stable CD4 counts above 500 cells/microliters. Our results indicate that long-term nonprogressors are a heterogeneous group with respect to viral load and HIV-1-specific immune responses, and that progression can occur even after 15 years of stable infection. However, in a subset of persons with the lowest viral loads and persistent nonprogressive infection, we detected strong CTL responses, whereas neutralizing antibody studies revealed weak to undetectable titers against a panel of 10 primary isolates. This study demonstrates that a vigorous in vivo activated HIV-1-specific CTL response can be part of the host immune response in stable nonprogressive HIV-1 infection, and that circulating activated CTL can be detected in the setting of an extremely low viral load. These results also indicate that long-term nonprogressing HIV-1 infection does not require the presence of broadly cross-reactive neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743084     DOI: 10.1089/aid.1996.12.585

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  91 in total

1.  Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.

Authors:  G S Ogg; S Kostense; M R Klein; S Jurriaans; D Hamann; A J McMichael; F Miedema
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Specific therapy regimes could lead to long-term immunological control of HIV.

Authors:  D Wodarz; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 3.  A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.

Authors:  D Wodarz; K M Page; R A Arnaout; A R Thomsen; J D Lifson; M A Nowak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

4.  Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.

Authors:  J C de Quiros; W L Shupert; A C McNeil; J C Gea-Banacloche; M Flanigan; A Savage; L Martino; E E Weiskopf; H Imamichi; Y M Zhang; J Adelsburger; R Stevens; P M Murphy; P A Zimmerman; C W Hallahan; R T Davey; M Connors
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Authors:  S I Staprans; P J Dailey; A Rosenthal; C Horton; R M Grant; N Lerche; M B Feinberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

Authors:  V Pancré; B Georges; G Angyalosi; F Castelli; A Delanoye; M Delacre; E Hachulla; B Maillere; A Bouzidi; C Auriault
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

7.  Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

Authors:  Maria C Jaimes; Holden T Maecker; Ming Yan; Vernon C Maino; Mary Beth Hanley; Angela Greer; Janice M Darden; M Patricia D'Souza
Journal:  J Immunol Methods       Date:  2010-08-19       Impact factor: 2.303

8.  Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.

Authors:  Yongjun Jiang; Fangyuan Zhou; Yao Tian; Zining Zhang; Rongmei Kuang; Jing Liu; Xiaoxu Han; Qinghai Hu; Junjie Xu; Hong Shang
Journal:  J Clin Immunol       Date:  2013-09-03       Impact factor: 8.317

Review 9.  The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.

Authors:  C Fraser; N M Ferguson; F de Wolf; R M Anderson
Journal:  Proc Biol Sci       Date:  2001-10-22       Impact factor: 5.349

10.  Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Authors:  Adriano Boasso; Monica Vaccari; Dietmar Fuchs; Andrew W Hardy; Wen-Po Tsai; Elzbieta Tryniszewska; Gene M Shearer; Genoveffa Franchini
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.